Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

GoodRx Holdings $1.3 billion IPO
Davis Polk advised the representatives of the several underwriters in connection with the $1.3 billion initial public offering of 39,807,691 shares of Class A common stock of GoodRx…
SoftBank ¥1.1 trillion global stock offering
Davis Polk advised the joint global coordinators in connection with the follow-on equity offering of 927,490,200 shares of common stock of SoftBank Corp. The shares were sold by…
Nuvei $805 million IPO
Davis Polk advised Nuvei Corporation in connection with its initial public offering of 30,961,539 subordinate voting shares for an aggregate amount of approximately $805 million. The…
Vitru $96 million IPO and Nasdaq listing
Davis Polk advised Vitru Limited in connection with its initial public offering of an aggregate of 6,000,000 common shares of Vitru at a price per common share of $16. The initial public…
American Well $853 million IPO and NYSE listing
Davis Polk advised American Well Corporation (“Amwell”) in connection with its initial public offering of 47,405,555 shares of Class A common stock for approximately $853 million in total…
Discovery Communications exchange offers of notes
Davis Polk advised the joint-lead dealer managers and the co-dealer managers in connection with the Rule 144A/Regulation S exchange offers by Discovery Communications, LLC of its 4.000%…
Sumo Logic $325.6 million IPO
Davis Polk advised the representatives of the several underwriters in connection with the $325.6 million initial public offering of 14,800,000 shares of common stock of Sumo Logic, Inc…
Medallia $575 million convertible notes offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Medallia, Inc. of $575 million aggregate principal amount of its 0.125%…
Back to top